Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin in Painful Chemotherapy-induced Peripheral Neuropathy
NCT02394951Completed
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Pregabalin First with Placebo First (2 arms). Primary endpoint: Change in Spontaneous Pain Intensity as a Function of Baseline MPT at 4 weeks. Started Apr 2015; status: completed.
02
Drugs
pregabalin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT02394951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02394951.